In a molecular diagnostic laboratory, having a system for tracking specimens, or assays, is integral to workflow efficiency and accuracy. Although streamlining this process often proves to be ...
A new lab assay developed by researchers at Fred Hutch Cancer Center could make diagnosis and treatment of small-cell lung cancer and non-small cell lung cancer easier. The blood-based test, also ...
We have written before about what specific blood panels reveal and how vitamin deficiencies show up in your bloodwork. Those ...
Bonsack is a patient advocate based in Moab, Utah. In the midst of a health crisis a few years ago, doctors repeatedly checked my thyroid-stimulating hormone (TSH), revealing an odd pattern: My test ...
Jay K. Varma ([email protected]), Cornell University, New York, New York. Jill Taylor, Association of Public Health Laboratories, Silver Spring, Maryland. Joshua M ...
The U.S. FDA’s stated policy is that it will not review emergency use authorizations (EUAs) for lab-developed tests (LDTs) for the COVID-19 pandemic, but that doesn’t mean labs are completely shut out ...
They began to test other plastics in the lab, and found that some, but not all, showed a similar effect, but which ones were problematic was hard to predict. For instance, the 1.5 ml microfuge tubes ...
Interference in laboratory assays is a concern since it can positively or negatively influence test results, which can affect patient care. Interferents could be endogenous or exogenous compounds.
The U.S. FDA’s stated policy is that it will not review emergency use authorizations (EUAs) for lab-developed tests (LDTs) for the COVID-19 pandemic, but that doesn’t mean labs are completely shut out ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results